Concepts (109)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Automobiles | 1 | 2017 | 88 | 0.68 | Why? |
| Facial Paralysis | 1 | 2021 | 231 | 0.67 | Why? |
| Bicycling | 1 | 2017 | 133 | 0.61 | Why? |
| Accidents, Traffic | 1 | 2017 | 464 | 0.48 | Why? |
| Locomotion | 1 | 2012 | 130 | 0.44 | Why? |
| Motor Vehicles | 1 | 2012 | 223 | 0.41 | Why? |
| Attitude | 1 | 2017 | 1481 | 0.35 | Why? |
| Social Mobility | 2 | 2018 | 54 | 0.34 | Why? |
| Body Weight | 1 | 2012 | 1074 | 0.31 | Why? |
| Carbon Dioxide | 1 | 2012 | 917 | 0.29 | Why? |
| Facial Nerve | 1 | 2021 | 83 | 0.22 | Why? |
| Alcohol-Related Disorders | 1 | 2018 | 84 | 0.17 | Why? |
| Air Pollutants | 1 | 2012 | 3110 | 0.14 | Why? |
| Immunization Schedule | 1 | 2021 | 1305 | 0.13 | Why? |
| Immunization, Secondary | 1 | 2021 | 1649 | 0.12 | Why? |
| Urinary Tract Infections | 1 | 2018 | 534 | 0.12 | Why? |
| Single-Blind Method | 3 | 2021 | 1283 | 0.12 | Why? |
| Gestational Age | 1 | 2017 | 1488 | 0.11 | Why? |
| Weather | 1 | 2017 | 581 | 0.11 | Why? |
| Community Health Services | 1 | 2020 | 1000 | 0.11 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 1 | 2021 | 1261 | 0.11 | Why? |
| Patient Compliance | 1 | 2020 | 1468 | 0.10 | Why? |
| Risk Management | 1 | 2017 | 1044 | 0.10 | Why? |
| Social Class | 1 | 2018 | 1360 | 0.10 | Why? |
| Self Report | 2 | 2021 | 3802 | 0.10 | Why? |
| Intention | 1 | 2017 | 1380 | 0.09 | Why? |
| Data Collection | 1 | 2017 | 1769 | 0.09 | Why? |
| United Kingdom | 4 | 2021 | 18046 | 0.08 | Why? |
| Perception | 1 | 2017 | 2827 | 0.08 | Why? |
| Immunogenicity, Vaccine | 1 | 2021 | 4624 | 0.07 | Why? |
| Adolescent | 7 | 2021 | 86841 | 0.07 | Why? |
| Antibodies, Neutralizing | 2 | 2021 | 25288 | 0.07 | Why? |
| Fear | 1 | 2017 | 3607 | 0.06 | Why? |
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 6653 | 0.05 | Why? |
| Sweden | 2 | 2018 | 1969 | 0.05 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.05 | Why? |
| Methenamine | 1 | 2018 | 3 | 0.05 | Why? |
| Hippurates | 1 | 2018 | 9 | 0.05 | Why? |
| Male | 12 | 2021 | 367725 | 0.05 | Why? |
| Double-Blind Method | 2 | 2020 | 5988 | 0.05 | Why? |
| Intention to Treat Analysis | 1 | 2020 | 673 | 0.05 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 9335 | 0.05 | Why? |
| Mannose | 1 | 2018 | 68 | 0.05 | Why? |
| Incidence | 2 | 2018 | 25622 | 0.05 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.05 | Why? |
| Health Status | 1 | 2012 | 3259 | 0.05 | Why? |
| Injections, Intramuscular | 1 | 2021 | 800 | 0.05 | Why? |
| Photoperiod | 1 | 2017 | 41 | 0.04 | Why? |
| Health Services Accessibility | 1 | 2021 | 10697 | 0.04 | Why? |
| Intergenerational Relations | 1 | 2018 | 102 | 0.04 | Why? |
| Exercise | 1 | 2017 | 6771 | 0.04 | Why? |
| Humans | 16 | 2021 | 930598 | 0.04 | Why? |
| Rain | 1 | 2017 | 108 | 0.04 | Why? |
| Wind | 1 | 2017 | 144 | 0.04 | Why? |
| Young Adult | 5 | 2021 | 93724 | 0.04 | Why? |
| CD4 Lymphocyte Count | 1 | 2021 | 1517 | 0.04 | Why? |
| Middle Aged | 9 | 2021 | 270681 | 0.04 | Why? |
| Accelerometry | 1 | 2017 | 228 | 0.04 | Why? |
| Estrogens | 1 | 2018 | 252 | 0.04 | Why? |
| Motor Activity | 1 | 2017 | 217 | 0.04 | Why? |
| HIV Infections | 1 | 2021 | 11620 | 0.04 | Why? |
| Adult | 8 | 2021 | 244371 | 0.03 | Why? |
| Treatment Failure | 1 | 2020 | 2106 | 0.03 | Why? |
| Child | 2 | 2021 | 70012 | 0.03 | Why? |
| Program Development | 1 | 2020 | 1089 | 0.03 | Why? |
| Secondary Prevention | 1 | 2018 | 762 | 0.03 | Why? |
| Stroke | 1 | 2017 | 8839 | 0.03 | Why? |
| Female | 10 | 2021 | 380317 | 0.03 | Why? |
| London | 1 | 2020 | 2166 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Safety | 1 | 2021 | 1583 | 0.03 | Why? |
| Program Evaluation | 1 | 2020 | 1929 | 0.03 | Why? |
| Phytotherapy | 1 | 2018 | 743 | 0.03 | Why? |
| Antiviral Agents | 2 | 2021 | 41703 | 0.03 | Why? |
| Probiotics | 1 | 2018 | 694 | 0.03 | Why? |
| South Africa | 1 | 2020 | 3326 | 0.03 | Why? |
| Aged | 5 | 2021 | 215776 | 0.03 | Why? |
| Cross-Sectional Studies | 2 | 2020 | 53120 | 0.03 | Why? |
| Sex Distribution | 1 | 2017 | 2083 | 0.02 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 1454 | 0.02 | Why? |
| Recurrence | 1 | 2018 | 3675 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.02 | Why? |
| Vaccines, Synthetic | 1 | 2021 | 3231 | 0.02 | Why? |
| England | 1 | 2020 | 5116 | 0.02 | Why? |
| Antibody Formation | 1 | 2021 | 4038 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2020 | 7268 | 0.02 | Why? |
| Nucleic Acid Amplification Techniques | 1 | 2021 | 3388 | 0.02 | Why? |
| Glucocorticoids | 1 | 2020 | 4431 | 0.02 | Why? |
| Surveys and Questionnaires | 1 | 2012 | 43792 | 0.02 | Why? |
| Seasons | 1 | 2017 | 4071 | 0.02 | Why? |
| Australia | 1 | 2017 | 6306 | 0.02 | Why? |
| Cohort Studies | 2 | 2018 | 36005 | 0.02 | Why? |
| Brazil | 1 | 2020 | 12582 | 0.02 | Why? |
| Adenosine Monophosphate | 1 | 2020 | 5652 | 0.02 | Why? |
| Alanine | 1 | 2020 | 5687 | 0.02 | Why? |
| Asymptomatic Infections | 1 | 2021 | 7218 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2021 | 10649 | 0.01 | Why? |
| Europe | 1 | 2017 | 12702 | 0.01 | Why? |
| Viral Load | 1 | 2021 | 15850 | 0.01 | Why? |
| Prospective Studies | 1 | 2021 | 43301 | 0.01 | Why? |
| Public Health | 1 | 2020 | 16359 | 0.01 | Why? |
| Treatment Outcome | 1 | 2020 | 51732 | 0.01 | Why? |
| Child, Preschool | 1 | 2017 | 36283 | 0.01 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2021 | 88759 | 0.01 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.01 | Why? |
| Risk Factors | 1 | 2017 | 71621 | 0.01 | Why? |
| Pandemics | 2 | 2021 | 389249 | 0.00 | Why? |
Goodman's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(109)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(298)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_